What’s in store for biotech VCs next year? Will Pfizer’s new R&D head do enough to appease investors? And should Adam get a position under the new Food and Drug Administration commissioner?
We discuss all this and more on this week’s episode of “The Readout LOUD.” Atlas Venture partner Bruce Booth joins us to discuss his annual year in review report, the influence of China, and what the new Trump administration might mean for innovation. Adam and Allison also recap the latest news in the life sciences, including a new science chief at Pfizer, a new job for Ned Sharpless, and the ongoing presidential appointments.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
